Drug
Gsk-2256294 clinical trials
Also written GSK2256294.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Development codes
- GSK2256294
- 5
Studies by the year they started
5 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 2
GlaxoSmithKline (3) · Vanderbilt University Medical Center (1) · Oregon Health and Science University (1)
Studies
Open first, then newest update. How each study uses gsk-2256294 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Soluble Epoxide Hydrolase Inhibition and Insulin ResistanceCompletedPhase 2Vanderbilt University Medical CenterNCT03486223Written as GSK2256294
- Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition TrialCompletedPhase 1/2Oregon Health and Science UniversityNCT03318783Written as GSK2256294
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese SmokersCompletedPhase 1GlaxoSmithKlineNCT01762774Written as GSK2256294
- To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic ConditionsCompletedPhase 1GlaxoSmithKlineNCT02262689Written as GSK2256294
- A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly SubjectsCompletedPhase 1GlaxoSmithKlineNCT02006537Written as GSK2256294
Codes
What other systems call gsk-2256294 · ClinicalTrials.gg INT006370
- Wikidata Q27282642gsk-2256294One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27282642 | gsk-2256294 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.